IMMUNOMEDICS INC·4

Feb 18, 7:11 PM ET

ITRI LORETTTA M 4

4 · IMMUNOMEDICS INC · Filed Feb 18, 2020

Insider Transaction Report

Form 4
Period: 2020-02-13
ITRI LORETTTA M
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-02-13+130,000130,000 total
    Exercise: $18.76Exp: 2027-02-13Common Stock, par value $0.01 per share (130,000 underlying)
Footnotes (1)
  • [F1]The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period.

Documents

1 file
  • 4
    a4.xmlPrimary

    4